Merus B.v.
Clinical trials sponsored by Merus B.v., explained in plain language.
-
New drug shows promise for Tough-to-Treat head and neck cancer
Disease control Recruiting nowThis study tests a new drug called petosemtamab against standard treatments for people with advanced head and neck cancer that has returned or spread and is no longer curable. About 500 adults who have already tried immunotherapy and chemotherapy will be randomly assigned to rece…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated May 17, 2026 11:52 UTC
-
New drug duo aims to shrink lung tumors in first-line therapy
Disease control Recruiting nowThis study tests whether adding petosemtamab to the standard immunotherapy pembrolizumab can shrink tumors in people with advanced non-small cell lung cancer who have not had prior treatment. About 180 adults with either squamous or non-squamous lung cancer will receive the combi…
Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated May 17, 2026 11:51 UTC
-
New combo therapy aims to shrink head and neck tumors better than standard treatment
Disease control Recruiting nowThis study tests whether adding petosemtamab to the standard immunotherapy pembrolizumab helps people with advanced head and neck cancer live longer or shrink their tumors more than pembrolizumab alone. About 700 adults whose cancer has spread or returned and whose tumors have a …
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC